Skip to main content
Premium Trial:

Request an Annual Quote

Theradiag Subsidiary Inks HIV/AIDS Diagnostics Deal with CNRS

NEW YORK (GenomeWeb News) – French molecular diagnostics firm Theradiag announced Monday that its microRNA diagnostics subsidiary Prestizia has inked two deals to develop HIV/AIDS assays in collaboration with the French National Center for Scientific Research (CNRS).

The first agreement relates to a 2013 collaboration between Theradiag, the drug development firm Splicos, and CNRS, which are jointly developing RNA-targeting therapeutics and companion diagnostic tests for HIV/AIDS and obesity. Specifically, Prestizia and CNRS have now agreed to develop an miRNA-based companion diagnostic for Splico's investigational HIV treatment SPL-464, as well as a predictive and monitoring test for the disease.

The second agreement extends an ongoing alliance between Prestizia and CNRS focused on the use of miRNAs as biomarkers of HIV/AIDS tropism to include long non-coding RNAs.

Additional terms of the deals were not disclosed.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.